Preoperative Trapped Lung Is Associated With Increased Mortality After Orthotopic Liver Transplantation.


Journal

Progress in transplantation (Aliso Viejo, Calif.)
ISSN: 2164-6708
Titre abrégé: Prog Transplant
Pays: United States
ID NLM: 100909380

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 8 12 2020
medline: 29 10 2021
entrez: 7 12 2020
Statut: ppublish

Résumé

Trapped lung, characterized by atelectatic lung unable to reexpand and fill the thoracic cavity due to a restricting fibrous visceral pleural peel, is occasionally seen in patients with end-stage liver disease complicated by hepatic hydrothorax. Limited data suggest that trapped lung prior to orthotopic liver transplantation may be associated with poor outcomes. What is the clinical significance of trapped lung in patients receiving orthotopic liver transplantation? We performed a retrospective analysis of patients who underwent liver transplantation over an 8-year period. Baseline clinical characteristics and postoperative outcomes of adult patients with trapped lung were analyzed and compared to the overall cohort of liver transplant recipients and controls matched 3:1 based on age, sex, Model for End-Stage Liver Disease (MELD) score, and presence of pleural effusion. Of the 1193 patients who underwent liver transplantation, we identified 20 patients (1.68%) with trapped lung. The probability of 1 and 2-year survival were 75.0% and 57.1%, compared to 85.6% and 80.4% (p = 0.02) in all liver transplant recipients and 87.9% and 81.1% (p = 0.03) in matched controls respectively. Patients with trapped lung had a longer hospital length of stay compared to the total liver transplant population (geometric mean 54.9 ± 8.4 vs. 27.2 ± 0.7 days, p ≤ 0.001), when adjusted for age and MELD score. Patients with trapped prior to orthotopic liver transplantation have increased probability of mortality as well as increased health care utilization. This is a small retrospective analysis, and further prospective investigation is warranted.

Identifiants

pubmed: 33280518
doi: 10.1177/1526924820978604
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47-54

Auteurs

Kathryn H Melamed (KH)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

David Dai (D)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Natasha Cuk (N)

Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Daniela Markovic (D)

Department of Biostatistics, 8783University of California at Los Angeles, Los Angeles, CA, USA.

Robert Follett (R)

Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.
8783UCLA Clinical and Translational Science Institute, Los Angeles, CA, USA.

Tisha Wang (T)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Roxana Cortes Lopez (RC)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Aditya S Shirali (AS)

Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Jane Yanagawa (J)

Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Ronald Busuttil (R)

Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Fady Kaldas (F)

Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Igor Barjaktarevic (I)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at 8783UCLA, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH